公司简介
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription...
关联新闻
- Johnson & Johnson to Buy Ollin Biosciences for $2.2 Billion
Johnson & Johnson has agreed to buy Ollin Biosciences, a clinical-stage biopharmaceutical company developing therapies for serious eye diseases.
- J&J's once-daily pill eases psoriatic arthritis symptoms in late-stage trial
Johnson & Johnson said on Saturday its once-daily pill eased symptoms in more patients with psoriatic arthritis than a placebo in a late-stage trial, potentially supporting expanded use of the drug.
- Smith+Nephew cuts outlook, confirms failed merger talks with J&J's orthopaedics unit
Smith+Nephew cuts outlook, confirms failed merger talks with J&J's orthopaedics unit
- The big winners of the tech wreck are biopharma stocks
Who would have believed that the boring healthcare industry would be the hottest stock sector of 2026? Companies like Johnson & Johnson, Quest Diagnostics and UnitedHealth Group have long been known f...
- Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trial
Johnson & Johnson on Saturday said its experimental once-daily oral prostate cancer drug caused tumors to disappear or shrink in an early-stage trial.
- Glucose monitoring devices for type 2 diabetes benefit even those not on insulin
Today we highlight a study that found benefits of wearable glucose monitoring devices for all patients with diabetes, regardless of insulin dependence. We also report on a positive trial of a J&J pil...
- Wells Fargo, Bank of America, Domino's, Johnson & Johnson, Inflation Data, and More to Watch This Week
Big bank earnings arrive, with Citi, Goldman Sachs, JPMorgan Chase, and more reporting. Consumer and producer price indexes and existing home sales data will provide a read on the economy.
- Contineum, J&J's depression drug fails to meet mid-stage trial goal
Contineum Therapeutics said on Monday an experimental depression drug it developed with Johnson & Johnson failed to meet the main goal of a mid-stage study.